Document Detail


Protamine reduces bleeding complications associated with carotid endarterectomy without increasing the risk of stroke.
MedLine Citation:
PMID:  20045609     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: Controversy persists regarding the use of protamine during carotid endarterectomy (CEA) based on prior conflicting reports documenting both reduced bleeding as well as increased stroke risk. The purpose of this study was to determine the effect of protamine reversal of heparin anticoagulation on the outcome of CEA in a contemporary multistate registry.
METHODS: We reviewed a prospective regional registry of 4587 CEAs in 4311 patients performed by 66 surgeons from 11 centers in Northern New England from 2003-2008. Protamine use varied by surgeon (38% routine use, 44% rare use, 18% selective use). Endpoints were postoperative bleeding requiring reoperation as well as potential thrombotic complications, including stroke, death, and myocardial infarction (MI). Predictors of endpoints were determined by multivariate logistic regression after associated variables were identified by univariate analysis.
RESULTS: Of the 4587 CEAs performed, 46% utilized protamine, while 54% did not. Fourteen patients (0.64%) in the protamine-treated group required reoperation for bleeding compared with 42 patients (1.66%) in the untreated cohort (P = .001). Protamine use did not affect the rate of MI (1.1% vs 0.91%, P = .51), stroke (0.78% vs 1.15%, P = .2), or death (0.23% vs 0.32%, P = .57) between treated and untreated patients, respectively. By multivariate analysis, protamine (odds ratio [OR] 0.32, 95% confidence interval [CI], 0.17-0.63; P = .001) and patch angioplasty (OR 0.46, 95% CI, 0.26-0.81; P = .007) were independently associated with diminished reoperation for bleeding. A single center was associated with a significantly higher rate of reoperation for bleeding (OR 6.47, 95% CI, 3.02-13.9; P < .001). Independent of protamine use, consequences of reoperation for bleeding were significant, with a four-fold increase in MI, a seven-fold increase in stroke, and a 30-fold increase in death.
CONCLUSION: Protamine reduced serious bleeding requiring reoperation during CEA without increasing the risk of MI, stroke, or death, in this large, contemporary registry. In light of significant complications referable to bleeding, liberal use of protamine during CEA appears warranted.
Authors:
David H Stone; Brian W Nolan; Andres Schanzer; Philip P Goodney; Robert A Cambria; Donald S Likosky; Daniel B Walsh; Jack L Cronenwett;
Related Documents :
6402129 - Variation in the use of angiography and carotid endarterectomy by neurologists in the u...
10567299 - Surgical patent foramen ovale closure for prevention of paradoxical embolism-related ce...
22684379 - Treating peripheral arterial disease percutaneously with atherectomy.
22998339 - A randomized trial of sugar-sweetened beverages and adolescent body weight.
8043289 - Neurological complications during myocardial revascularization using warm-body, cold-he...
22449449 - Reconstruction of distal urethral strictures confined to the glans with circular buccal...
20927649 - Treatment of budd-chiari syndrome with urokinase following predilation in patients with...
21756859 - King lt-d use by urban basic life support first responders as the primary airway device...
21336149 - Effect of a failed trabectome on subsequent trabeculectomy.
Publication Detail:
Type:  Journal Article; Multicenter Study     Date:  2010-01-04
Journal Detail:
Title:  Journal of vascular surgery     Volume:  51     ISSN:  1097-6809     ISO Abbreviation:  J. Vasc. Surg.     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-03-08     Completed Date:  2010-04-13     Revised Date:  2012-10-03    
Medline Journal Info:
Nlm Unique ID:  8407742     Medline TA:  J Vasc Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  559-64, 564.e1     Citation Subset:  IM    
Affiliation:
Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA. David.H.Stone@Hitchcock.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Endarterectomy, Carotid / adverse effects*,  mortality
Female
Heparin Antagonists / adverse effects,  therapeutic use*
Humans
Logistic Models
Male
Myocardial Infarction / etiology,  mortality
New England
Odds Ratio
Postoperative Hemorrhage / etiology,  mortality,  prevention & control*
Prospective Studies
Protamines / adverse effects,  therapeutic use*
Registries
Reoperation
Risk Assessment
Risk Factors
Stroke / etiology*,  mortality
Time Factors
Treatment Outcome
Chemical
Reg. No./Substance:
0/Heparin Antagonists; 0/Protamines

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ability of physicians to diagnose congestive heart failure based on chest X-ray.
Next Document:  A portable high-intensity focused ultrasound device for noninvasive venous ablation.